Amphix Bio earned FDA breakthrough device designation for a bone regeneration drug-device combination, according to an Oct. 3 news release. The designation applies to the use of a therapeutic device ...

Although private equity is a debated topic in orthopedic private practice, some leaders believe it can be a viable option as long as the right people are involv ...

From new technologies and surgical techniques, several hospitals and practices have added to their spine and orthopedic programs in September.

The Catamaran Mainsail study is ongoing across six clinical sites in the U.S. The implant is designed to transfix the SI joint along its longitudinal axis and provides immediate fixation and ...